Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood
1999

MIA mRNA Levels in Melanoma and Other Cell Types

Sample size: 35 publication Evidence: moderate

Author Information

Author(s): Vries T J de, Fourkour A, Punt C J A, Diepstra H, Ruiter D J, Muijen G N P van

Primary Institution: University Hospital Nijmegen

Hypothesis

MIA mRNA is not exclusively transcribed in melanoma cells.

Conclusion

MIA is not a suitable marker gene for detecting minimal amounts of melanoma cells in blood or target organs.

Supporting Evidence

  • MIA mRNA was detected in 16 out of 19 melanoma cell lines.
  • MIA mRNA was detected in 7 out of 16 non-melanoma cell lines after 30 cycles of PCR.
  • MIA mRNA was detected in all cell lines after 60 cycles of PCR.
  • MIA mRNA was detected in 14 out of 14 blood samples of melanoma patients after 60 cycles of PCR.
  • MIA mRNA was detected in 5 out of 6 blood samples of non-melanoma patients after 60 cycles of PCR.
  • MIA mRNA was detected in 7 out of 7 blood samples of healthy volunteers after 60 cycles of PCR.

Takeaway

The study found that a gene called MIA is present in both melanoma and non-melanoma cells, which means it can't be used to find melanoma cells in blood.

Methodology

The study used RT-PCR to detect MIA mRNA in melanoma and non-melanoma cell lines and blood samples.

Limitations

MIA may not be effective for detecting melanoma cells in blood due to low levels in various cell types.

Participant Demographics

Blood samples were taken from melanoma patients, non-melanoma patients, and healthy volunteers.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690808

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication